BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 21215350)

  • 1. Cord blood-derived cytokine-induced killer cells biotherapy combined with second-line chemotherapy in the treatment of advanced solid malignancies.
    Niu Q; Wang W; Li Y; Qin S; Wang Y; Wan G; Guan J; Zhu W
    Int Immunopharmacol; 2011 Apr; 11(4):449-56. PubMed ID: 21215350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective study of chemotherapy in combination with cytokine-induced killer cells in patients suffering from advanced non-small cell lung cancer.
    Wu C; Jiang J; Shi L; Xu N
    Anticancer Res; 2008; 28(6B):3997-4002. PubMed ID: 19192663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of advanced gastric cancer by chemotherapy combined with autologous cytokine-induced killer cells.
    Jiang J; Xu N; Wu C; Deng H; Lu M; Li M; Xu B; Wu J; Wang R; Xu J; Nilsson-Ehle P
    Anticancer Res; 2006; 26(3B):2237-42. PubMed ID: 16821594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous cytokine-induced killer cell therapy in lung cancer patients: a retrospective study.
    Zhang J; Zhu L; Du H; He X; Yin Y; Gu Y; Liu L; Lu K; Guo R; Liu P; Shu Y
    Biomed Pharmacother; 2015 Mar; 70():248-52. PubMed ID: 25776508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Growth inhibition of human hepatocellular carcinoma xenograft in nude mice by combined treatment with human cytokine-induced killer cells and chemotherapy].
    Shi M; Yao L; Wang FS; Lei ZY; Zhang B; Li WL; Liu JC; Tang ZR; Zhou GD
    Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):465-8. PubMed ID: 15555334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, controlled trial of postoperative adjuvant cytokine-induced killer cells immunotherapy after radical resection of hepatocellular carcinoma.
    Hui D; Qiang L; Jian W; Ti Z; Da-Lu K
    Dig Liver Dis; 2009 Jan; 41(1):36-41. PubMed ID: 18818130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maintenance therapy with autologous cytokine-induced killer cells in patients with advanced epithelial ovarian cancer after first-line treatment.
    Liu J; Li H; Cao S; Zhang X; Yu J; Qi J; An X; Yu W; Ren X; Hao X
    J Immunother; 2014; 37(2):115-22. PubMed ID: 24509174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Proliferation and cytotoxicity of RetroNectin-activated cytokine-induced killer cells against cisplatin-resistant lung carcinoma cell].
    Ren W; Wang Z
    Sheng Wu Gong Cheng Xue Bao; 2008 Aug; 24(8):1373-80. PubMed ID: 18998538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of cord blood-derived cytokine-induced killer cells in treatment of patients with malignancies.
    Zhang Z; Wang L; Luo Z; Zhao X; Huang J; Li H; Yang S; Zhao X; Zhang L; Li L; Wang F; Huang L; Zhang Y
    Cytotherapy; 2015 Aug; 17(8):1130-8. PubMed ID: 25963952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic characterization and anti-tumor effects of cytokine-induced killer cells derived from cord blood.
    Zhang Z; Zhao X; Zhang T; Wang L; Yang L; Huang L; Li F; Liu J; Yue D; Wang F; Li J; Guan F; Xu Y; Zhang B; Zhang Y
    Cytotherapy; 2015 Jan; 17(1):86-97. PubMed ID: 25457278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical effects of autologous dendritic cells combined with cytokine-induced killer cells followed by chemotherapy in treating patients with advanced colorectal cancer: a prospective study.
    Lin T; Song C; Chuo DY; Zhang H; Zhao J
    Tumour Biol; 2016 Apr; 37(4):4367-72. PubMed ID: 26499782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cytokine-induced killer cell treatment in colorectal cancer patients: a retrospective study.
    Zhang J; Zhu L; Zhang Q; He X; Yin Y; Gu Y; Guo R; Lu K; Liu L; Liu P; Shu Y
    Biomed Pharmacother; 2014 Jul; 68(6):715-20. PubMed ID: 25107840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimized protocols for generation of cord blood-derived cytokine-induced killer/natural killer cells.
    Li Y; Schmidt-Wolf IG; Wu YF; Huang SL; Wei J; Fang J; Huang K; Zhou DH
    Anticancer Res; 2010 Sep; 30(9):3493-9. PubMed ID: 20944128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cord blood-derived and peripheral blood-derived cytokine-induced killer cells are sensitive to Fas-mediated apoptosis.
    Durrieu L; Dieng MM; Le Deist F; Haddad E
    Biol Blood Marrow Transplant; 2013 Sep; 19(9):1407-11. PubMed ID: 23856078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical efficacy of immunotherapy of dendritic cell and cytokine-induced killer cell combined with chemotherapy for treatment of multiple myeloma].
    Zhong GC; Yan B; Sun Y; Zhang XY; Chen J; Su Y; Sun HP; Zhu B
    Zhonghua Xue Ye Xue Za Zhi; 2012 Dec; 33(12):1000-3. PubMed ID: 23363790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Short-term curative efficacy of cytokine-induced killer cells combined micro-invasive treatments on hepatocellular carcinoma].
    Zhou QM; Wu PH; Zhao M; Wang QJ; Huang LX; Li YQ; Chen SP; Xia JC
    Ai Zheng; 2006 Nov; 25(11):1414-8. PubMed ID: 17094912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeated transfusions of autologous cytokine-induced killer cells for treatment of haematological malignancies in elderly patients: a pilot clinical trial.
    Yang B; Lu XC; Yu RL; Chi XH; Liu Y; Wang Y; Dai HR; Zhu HL; Cai LL; Han WD
    Hematol Oncol; 2012 Sep; 30(3):115-22. PubMed ID: 22972689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase I trial of autologous cytokine-induced killer cells for the treatment of relapsed Hodgkin disease and non-Hodgkin lymphoma.
    Leemhuis T; Wells S; Scheffold C; Edinger M; Negrin RS
    Biol Blood Marrow Transplant; 2005 Mar; 11(3):181-7. PubMed ID: 15744236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy with or without autologous cytokine-induced killer cell transfusion as the first-line treatment for stage IV gastrointestinal cancer: a phase II clinical trial.
    Xu YC; Xu Q; Li JJ; Gu XF; Lin XL; Sun L; Lu HM; Tang L; Ma Y; Lu Z; Wang HX
    J Cancer Res Clin Oncol; 2016 Jun; 142(6):1315-23. PubMed ID: 26941189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of erlotinib plus dendritic cells and cytokine-induced killer cells in maintenance therapy of advanced non-small cell lung cancer.
    Shi SB; Tang XY; Tian J; Chang CX; Li P; Qi JL
    J Immunother; 2014 May; 37(4):250-5. PubMed ID: 24714359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.